Ascentage Pharma and Tanner Pharma Group initiate a global innovative named Patient Program
Tanner will be the supplier of olverembatinib to healthcare providers on a named patient basis in countries where the drug is not commercially available.
Tanner will be the supplier of olverembatinib to healthcare providers on a named patient basis in countries where the drug is not commercially available.
AstraZeneca and Indian Society of Nephrology aim to help clinicians and healthcare practitioners to provide holistic kidney care to their patients.
The region's digital health market, valued at USD 40.3 billion in 2021, is expected to expand to USD 326.7 billion by 2030 at a CAGR of 26.5 per cent.
Better serving global partners and advancing healthcare innovation
The funds raised in the seed round will be used for research and development of Shri Chyawan Ayurved Product
The partnership will accelerate stockpiling, channel distribution and hospital access for the amubarvimab/romlusevimab combination in China
Orion to receive an upfront payment of USD 290 million
To strengthen the integrated human-centric preventive health screening ‘Phygital’ ecosystem in India
Syngene's collaboration with Zoetis started in 2011
Novavax' vaccine is the first protein-based COVID-19 vaccine authorized in the U.S.
Subscribe To Our Newsletter & Stay Updated